author-photo

Sosina Makonnen

Regeneron

10

Papers

67

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

A biparatopic antibody-drug conjugate to treat MET-expressing cancers, including those that are unresponsive to MET pathway blockade

2021 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (1)
Preclinical PET imaging with the novel human antibody 89Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissues.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids

2020 Bioorganic & Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (0)
A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer

2019 Science Translational Medicine
Show All
- Source
- Cite
- Save
Citations (39)
Abstract 3033: Immuno-PET detection of LAG-3 expressing intratumoral lymphocytes using the zirconium-89 radiolabeled fully human anti-LAG-3 antibody REGN3767

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (4)
Preclinical activity of the novel anti-Prolactin Receptor (PRLR) antibody drug-conjugate REGN2878-DM1 in PRLR positive breast cancers

2017 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (11)
Abstract C126: PRLR ADC: A novel antibody drug-conjugate for the treatment of PRLR positive breast cancer

2015 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)